Stillen

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

GastritisChronic Gastritis

40 competitors in Gastritis

#DrugCompanyPhaseTrials

1

Prevacid

Takeda

Approved

12

Nexium

DDexcel Pharma Technologies Ltd.

Approved

23

Prilosec

DDexcel Pharma Technologies Ltd.

Approved

24

Takecab

PPhathom Pharmaceuticals, Inc.

Approved

15

Rabeprazole ER

Eisai

Approved

16

Amoxil

GGlobal Antibiotics Research and Development Partnership

Approved

—7

Mucosta

Otsuka

Phase 3

—8

Biaxin

AbbVie

Phase 2

19

Entyvio

Takeda

Phase 2

110

Fexuprazan Hydrochloride

Daewoong Pharmaceutical Co. LTD.

Approved

1Show 11 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Chronic Gastritis2 trials

A Study to Evaluate the Safety and Efficacy of DA9601 for Acute and Chronic Gastritis and to Determine the Optimal Clinical Dosage and Administration

Completed·DDong-A ST Co., Ltd.·Phase 2·NCT07139886·212 enrolled

Clinical Trial to Evaluate the Efficacy and Safety of DA-5219 in Patients With Acute or Chronic Gastritis

Completed·DDong-A ST Co., Ltd.·Phase 3·NCT06151210·467 enrolled

Efficacy1 trial

A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab.

Completed·DDong-A ST Co., Ltd.·Phase 4·NCT01817556·258 enrolled

Efficacy and Safety1 trial

A Study to Evaluate the Efficacy and Safety of DA-5204

Unknown status·DDong-A ST Co., Ltd.·Phase 3·NCT02282670·434 enrolled

Gastritis1 trial

Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients

Completed·Chong Kun Dang Pharmaceutical·Phase 4·NCT02356679·230 enrolled

Randomized1 trial

A Multicenter, Double Blinded, Randomized, Parallel Assignment Study to Demonstrate the Efficacy of DA9601

Completed·DDong-A ST Co., Ltd.·Phase 4·NCT01912066·520 enrolled

Details

Drug Info

Related News